Statement by Mr. Nicolas Sarkozy, President of the Republic, on the assessment of four years of implementation of the Alzheimer Plan, in Paris on February 1, 2012.

France Nicolas Sarkozy · President of France

1 February 2012 · 4th anniversary of the Alzheimer Plan · Paris, France

Context
Sarkozy addressed a gathering in Paris on February 1, 2012, to mark the four-year anniversary of France's Alzheimer Plan and assess its implementation progress.
Main themes
Alzheimer's Plan four-year assessment, fight against Alzheimer's disease, patient and family support, research progress, dignity and respect for vulnerable persons, societal attitudes toward dementia, international recognition of French health policy, human dignity and ethics of care, caregiver mobilization, bioethics
Duration
~26 min
77th percentile
Words
3,098
77th percentile
Sentences
173
85th percentile
Readability
57
81st percentile
Grade
9.7
17th percentile
Syntax
2.86
29th percentile
Vocabulary
2.08
23rd percentile

Translated from French

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 74%73%
  • Ceremonial 11%10%
  • Economic 8%8%
  • Institutional 8%8%
  • Geopolitical 0%0%
  • Technological 0%0%
  • Environmental 0%0%
  • Not in focus 1%

173 sentences in 55 paragraphs

Ladies and gentlemen, good morning,

Ladies Ministers,

I am pleased to be with you today to celebrate the 4th anniversary of the Alzheimer Plan. We wanted this Plan to bring all our forces together in the fight against this disease. To understand this disease, to treat it, and to support those affected. These are three inseparable aspects. The progress to be made was considerable, it must be said. The delay was immense. This disease is a tragedy. We had to respond to the suffering of patients and their families.

As early as September 2007, I asked Joël MENARD, whom I thank, to provide us with his expertise. Four years ago, to the day, thanks to your collective work, we established a Plan of 44 measures that covers all aspects of the fight against the disease.

Since 2008, with the leaders of the Plan, including Roselyne Bachelot, under the impetus of Florence LUSTMAN, whose tenacity and energy I want to commend, and also with the France Alzheimer association, dear Marie-Odile DESANA, we have met every six months, with the ministers, to record progress, advancements, to correct delays, when there were any, it is true, and to move forward together.

We have carried out exemplary work. There was a societal problem that everyone knew about and at the same time energies among researchers, caregivers, and associations. Everyone was ready to mobilize, and yet France was falling behind. Today, we have made such progress that the Alzheimer Plan is envied, so to speak, around the world. We hosted the international congress on the disease in Paris last July, and our American friends told us simple words, I want to quote them: "The Alzheimer Plan launched in France in 2008 is a model of what could be done in other countries." Our American friends are not so indulgent that we should take positive comments lightly.

The Alzheimer Plan is being watched closely around the world: in the United Kingdom, South Korea, India, the United States, the Netherlands, Sweden! Yes, Sweden is interested in what is being done in France on a social issue! And a few months ago, a French weekly listed the 100 reasons to be optimistic about our country.

Well, the Alzheimer Plan was on that list! I confess, I did not necessarily expect this form of recognition, neither for the Alzheimer Plan nor for any other subject, but it does not matter, the suffering is so great for families and people with Alzheimer’s. It is such an incomprehensible experience to live and feel that our duty was to commit ourselves.

Of course, the time is not yet for assessment; there is still a year left in this Plan to make progress, and our mobilization must remain unwavering.

But it seems to me that our first great satisfaction is that the collective view of society on Alzheimer’s disease has changed.

Alzheimer’s disease and related diseases are, it must be said, diseases that were not talked about, or not enough. When the diagnosis was made, for patients, for their families, it was disaster, despair, and, on top of that, they were ashamed.

In the face of old age, we could have chosen to give up, to confine our elders to hospices, essentially places of relegation. To overwhelm patients, to isolate them, is not the solution we want for our country. The solution is an ethical approach; it is the intelligence and humanity of care. The degree of advancement of a society is measured by the fate it reserves for the most fragile of its members. Ultimately, it is almost a question of honor, because Alzheimer’s patients could be us; it can be us. We have just had the luck to escape it, temporarily. So the other, this extraordinary stranger who has the disease, could be someone we love, and it could be ourselves. When we treat Alzheimer’s patients and their families with dignity and respect, we are only treating ourselves well. There is no difference.

So, fundamentally, it is also our conception of life and the dignity of the person. These are subjects that touch the heart of our human condition. It is not about being, at all costs, modern, simply to say that we are. It is about protecting the values that underpin our society and our conception of the human person.

With Alzheimer’s, this person is weakened; they are sometimes a stranger to themselves; they are different; they are extraordinarily fragile, but they are a human being. They are a part of humanity; they are not foreign to humanity. I would even say that they are even more human because they are even weaker, and we can even associate the degree of humanity with the weakness we feel for ourselves or for others. We had this debate during the revision of the bioethics laws, a debate that showed the French people's adherence to the various principles that underpin this legislation: respect for human dignity. I would like to say, the weaker the person is, the more they are a stranger to themselves, the more they must be respected. This is exactly the opposite reflex to what I sometimes hear. It is precisely because they are at the extreme limit of weakness that they must be at the extreme beginning of respect. It is the refusal of any form of commodification and exploitation of the human body.

So with all the ethical work that has been done around the Alzheimer Plan, you have shown that this disease can be managed, that we can even make it recede by advancing medicine. Displaying a national priority is that.

This Plan is a hope for caregivers. This disease has the singularity that it inexorably ends not by wearing out families, not by wearing them out, but by exhausting them. I contest the word "wear," I say: it exhausts them physically and morally. I want to tell families that it is because we are aware of this that we wanted concrete responses, because their commitment to their loved ones deserves respect.

And in a financial context that everyone knows the constraints of, we are dedicating 1.6 billion euros to the Alzheimer Plan over the period 2008-2012. This is not to say that it is sufficient, but I do not know if you realize what it means to extract 1.6 billion simply to restore hope.

Our second satisfaction is having transformed this mobilization into concrete achievements.

An adapted care approach allows for a reduction in behavioral disorders and, above all, less reliance on medication. We have made these advances thanks to the quality of professionals, men and women, who are with patients every day: they are better trained, better coordinated, more accessible in the territory. We have disseminated best practices in terms of announcing and supporting the diagnosis.

I also think of the role of the family doctor, who knows their patients well. Strengthening primary care was about strengthening the entire health system and relieving hospitals of tasks that private doctors can perform under better conditions. There cannot be only hospitals in the fight against Alzheimer’s.

It was essential to enhance the care of patients. This has now been achieved thanks to the new medical convention signed, a first, dear Nora BERRA, by almost all medical unions and the entire medical community.

This new convention enhances the involvement of the general practitioner, thanks to a special consultation for Alzheimer’s disease that will come into effect in March. We cannot compare this consultation with that for treating a sore throat or a cold. I apologize for saying things like this, which I deeply believe. Equality does not mean treating all consultations the same way: "Doctor, I have a cold, I have a sore throat, I have the flu, or I have an Alzheimer’s diagnosis." It is not quite the same thing; we cannot consider that we will compensate for things in the same way.

Allow me also to recall the contribution of the creation of the regional health agencies, which everyone has been talking about for 20 years, and which allows for cooperation between city medicine and hospital medicine.

The new ground structures provided for by the Plan are now a reality.

Everyone knows the importance of early diagnosis, of course, because in addition to discovering the ravages of this disease, we have understood that it can be contracted very young. Imagine the shock, and this is the role of memory consultations, available in more than 500 hospital reception points, to which are added private consultations.

The MAIA, the famous reception and integration houses, are the keystone of the Alzheimer Plan. I believe that without creating new structures, we have integrated Alzheimer services into a network. This is the entire logic of this new organization.

Previously, a patient and their family would contact an average of three structures, sometimes more, before finding the right care. Today, there is a single intermediary. This means that we are faster, more humane, and more effective.

In total, 55 MAIA currently welcome patients and their families. An additional 100 houses are in the process of being selected. By the end of 2012, we will have a network of 155 houses.

So, of course, there is Alzheimer’s, and there is also the problem of old age in general. The level of national solidarity commitment represents 25 billion euros per year for the elderly. The number of places in facilities capable of accommodating dependent individuals has increased by 70% since 2006. 70% more! That is an additional billion euros dedicated to this considerable problem.

Of course, I recognize the path we still have to travel for the care of dependency. I have not abandoned the goal of more significant advancements.

Dealing with the issue of dependency comprehensively in the current context would not have been responsible, and I stand by that. Simply because we cannot want to finance dependency simply by creating debt and thus deferring its financing to future generations.

I am still determined to implement this reform, I tell you, and I prefer to say it frankly; I must also take into account extremely difficult financial constraints. And I could not tell the French: "Here, we are asking you to work 2 more years for retirement, we are asking for efforts, and at the same time, I am putting an additional billion for dependency." Understand me, it is not that it is not necessary. Of course, it is necessary, but on my desk, I have not arbitrated between unnecessary expenses and necessary expenses. That would be too easy. I only have to arbitrate between necessary expenses and very necessary expenses, even between very necessary expenses and very, very necessary expenses.

I fully assume the decision I made to postpone the dependency reform. I told the ministers; I do not hide behind them; that is not my style at all. I prefer to tell you the truth as it is; I will only carry out this reform when I have the means to finance it credibly, and not to create a chasm or to find myself with structures for which we cannot pay the staff, or structures where there will not be enough supervision and that will not be able to cope. I think we need to be serious. I think we need to be reasonable. I think we need to make the right decisions at the right time.

I just want to remind you of one figure: in 2009, in 6 months, France's tax revenues decreased by 22%. Expenditures did not decrease by 22%, but revenues decreased by 22%.

Helping caregivers also means informing them so that they are less bewildered. Two days of training per year are offered to each family caregiver. France Alzheimer has thus trained 6,000 caregivers; that is no small feat.

Care in healthcare facilities has been strengthened. 65 special units known as cognitive-behavioral units -- it is really fantastic vocabulary! We sound so knowledgeable when we speak with your vocabulary; it is quite exceptional! --, 65 already exist, and 113 are ready to start. We will reach 120 units by the end of 2012, in accordance with the objectives of the Plan.

Let us be realistic: even if some areas have all the solutions of the Plan, I know that things are not moving everywhere as quickly as we would like. Because we need to bring together actors from very different backgrounds. Because we need to adapt responses to local specificities, because we need to learn new modes of care. But things are progressing. I am not here to tell you that everything is fine, that we are at the end of things, no. I am aware. No one can contest that there has been exceptional progress. But there are still gaps, and there are considerable efforts to be made.

I can see that if I had to take care of someone who had the disease, I would say: "Well, come on, I want this to go faster." I completely understand that. But once again, I have to arbitrate between so many expenses and issues.

Finally, the third source of satisfaction is research.

We have thus laid the foundations for coordinated research that has now reached a level of global excellence.

The international symposium on "Advances in Research" was held today in Marigny. I commend those of you who participated.

With many leading French researchers in this field, as well as foreign researchers, you have reviewed the research on Alzheimer's disease in the three major areas of fundamental research, clinical research, and research in the humanities and social sciences.

I am pleased to see that the research component of the Alzheimer Plan, led by the Foundation and its director Philippe AMOUYEL, whom I salute, has achieved the objectives set in 2008. 140 research projects have been funded for a total amount of 84 million euros, 150 researchers have been recruited, and 600 doctors have been trained in clinical research.

Other countries have followed the same path.

Frankly, what had frightened me when I first became interested in this subject was that doctors and researchers told me: "We know nothing. Nothing at all." We were aware that there were brown plaques forming in the brain. I am at the extreme limits of my technical knowledge in this area! You are right, I see the worried faces of the researchers: "What is he going to tell us!" Nothing more. Nothing more, except that what I want to tell you is that everything we do for MAIA, for diagnosis, for caregivers, is very good, it is necessary. But I tell the researchers, the heart of the matter is you, it is the cure, it is the medication, you are at the heart of the battle. You understand, my dream is that we no longer need all of this, because we would have the solution. And so, we will continue to mobilize resources for you.

Medical research must progress on this subject.

I am also convinced that this issue of cell degeneration, like everything we can find on Alzheimer’s, can help us with other subjects. I am convinced that there are research families on this issue of cells that no longer function. What is extraordinary is that instead of dying, they proliferate, as if the fact of being unwell overtakes the cells in our body that are functioning well. It was a moment of popularization and improvisation! This is what I have retained from countless meetings with people far more competent than I am.

In summary, I want to tell you that the mobilization for Alzheimer’s, as for health, is our heritage and therefore, naturally, whether we are on the left or the right, it is health that we want to prioritize. I can see that someone with a different illness than those in the indicated Plan—cancer, Alzheimer’s—might say: "And me?" Of course! But still, I have chosen to support the ministers and to go with this Plan, because I believe that there are diseases that are true epidemics, epidemics not in the sense of epidemiology, but epidemics by the number of families affected. Take cancer: there is not a family that is not broken, troubled by cancer. For Alzheimer’s disease, I understood that having a Plan would prevent panic, but that does not mean that we are not researching for others, and above all, that does not mean, I want to convey this idea, that when we research Alzheimer’s, we are not researching for others. Ultimately, perhaps you will find things that will apply to other diseases and that all of this will benefit all patients. So, there is no need to feel complex about that.

Finally, whatever deadlines will occupy our country, everything we do only makes sense if we inscribe it in the long term. You understand: in the long term. It is in the long term that we will make progress. Therefore, Alzheimer’s should not belong to a left-right debate, an opposition-government debate, a debate of alternation. I myself took up the first Cancer Plan of President CHIRAC, because I considered it to be something very important and that we needed to make a number two, and it would have been absolutely ridiculous to abandon the Cancer Plan.

What I wish for the Alzheimer Plan until 2012 is that we work together for a new Plan, because what matters is to inscribe our action in the long term.

Thank you for listening to me. Then, I would like to tell you one last thing, which is that for the families who care for their sick loved ones, this evokes great respect.

And I would like to thank the researchers, the doctors, the professionals who care for the elderly, because the temptation of our society is to set them aside. It must be said that the specialties of aging were not the most popular among medical students, they are not always the most spontaneously rewarding.

I want to thank those of you who make the deliberate choice to care for our oldest compatriots even if Alzheimer’s affects young people. We need you, and perhaps you do not feel valued by society’s gaze, but you must be valued by the desperate gaze of the patient and their families. What I truly wish from the bottom of my heart is that there are more medical students who say: "Disciplines like gerontology are disciplines of the future." There you go, this is real medicine, it is even cutting-edge medicine.

This was not at all in the speech, but it is exactly what I thought.

Thank you for your attention.